Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pharma majors lose hundreds of millions in Greek revenue

This article was originally published in Scrip

Executive Summary

Major pharmaceutical companies have lost hundreds of millions of dollars in sales revenue between them due to the sovereign debt crisis in Greece. Roche, which has been the most public of the companies involved, has said that its acceptance of Greek government bonds as payment for a €400 million debt from hospitals, caused it an immediate loss of more than 25% (€100 million), the discount it had to accept in order to resell the bonds. Meanwhile, that loss has been compounded by the loss of sales to market contraction as firms impose increasingly forceful limits on their debtors in the healthcare system.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts